Department of Experimental and Clinical Pharmacology, Medical University in Lublin, Poland.
Laboratory of Cellular and Molecular Pharmacology, Department of Experimental and Clinical Pharmacology, Medical University in Lublin, Poland.
Eur J Pharmacol. 2020 Sep 15;883:173363. doi: 10.1016/j.ejphar.2020.173363. Epub 2020 Jul 11.
Hypothyroidism frequently manifests with altered mood and disturbed cognition. Kynurenic acid may influence cognition through antagonism of N-methyl-d-aspartate receptors (NMDA) and α7 nicotinic receptors. In here, thyroid hormones effects on kynurenic acid synthesis in rat cortical slices and on kynurenine aminotransferases (KATs) activity in semi-purified cortical homogenates were studied. Furthermore, brain kynurenic acid levels and KATs activities were evaluated in experimental model of hypothyroidism, induced by chronic administration of 0.05% propylthiouracil in drinking water. In vitro, L-thyroxine (T) and 3,3,5-triiodothyronine (T), reduced kynurenic acid synthesis and KATs activities (IC ~ 50-150 μM). In vivo, propylthiouracil increased cortical, hippocampal and striatal, but not cerebellar kynurenic acid content (192%, 142% and 124% of control, respectively), despite uniformly decreased KAT II activity and lower cortical and striatal KAT I activity. T application to hypothyroid animals restored kynurenic acid levels to control values and reversed enzymatic changes. T alone did not change brain kynurenic acid levels, despite increased activities of brain KATs. Hence, thyroid hormones modulate kynurenic acid levels by two opposing mechanisms, stimulation of KATs activity, most probably transcriptional, and direct, post-translational inhibition of KATs. Lack of correlation between KATs activity and kynurenic acid level may reflect the influence of T on organic anion transporter and result from impaired removal of kynurenic acid from the brain during hypothyroidism. Our data reveal novel mechanism linked with thyroid hormones deficiency and imply the potential involvement of increased brain kynurenic acid in the hypothyroidism-related cognitive disturbance.
甲状腺功能减退症常表现为情绪改变和认知障碍。犬尿氨酸酸可能通过拮抗 N-甲基-D-天冬氨酸受体 (NMDA) 和α7 烟碱型乙酰胆碱受体影响认知。在这里,研究了甲状腺激素对大鼠皮质切片中犬尿氨酸酸合成的影响,以及对半纯化皮质匀浆中犬尿氨酸氨基转移酶 (KAT) 活性的影响。此外,还评估了在慢性给予饮用水中 0.05%丙基硫氧嘧啶诱导的甲状腺功能减退症实验模型中,大脑犬尿氨酸酸水平和 KAT 活性。在体外,L-甲状腺素 (T) 和 3,3,5-三碘甲状腺原氨酸 (T) 降低了犬尿氨酸酸的合成和 KAT 活性 (IC ~ 50-150 μM)。在体内,丙基硫氧嘧啶增加了皮质、海马和纹状体,但不增加小脑的犬尿氨酸酸含量 (分别为对照的 192%、142%和 124%),尽管 KAT II 活性均匀降低,皮质和纹状体的 KAT I 活性降低。向甲状腺功能减退症动物给予 T 可将犬尿氨酸酸水平恢复至对照值,并逆转酶的变化。T 单独使用不会改变大脑犬尿氨酸酸水平,尽管脑 KAT 活性增加。因此,甲状腺激素通过两种相反的机制调节犬尿氨酸酸水平,即刺激 KAT 活性,可能是转录,以及直接的、翻译后抑制 KAT。KAT 活性与犬尿氨酸酸水平之间缺乏相关性可能反映了 T 对有机阴离子转运体的影响,并且是由于甲状腺功能减退症期间犬尿氨酸酸从大脑中清除受损所致。我们的数据揭示了与甲状腺激素缺乏相关的新机制,并表明大脑犬尿氨酸酸增加可能与甲状腺功能减退症相关的认知障碍有关。